Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 71,325 |
|
|||||
| News | - | ||||||
| Day High | 7.21 | Low High |
|||||
| Day Low | 6.65 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Pulse Biosciences Inc | PLSE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.65 | 9.72% | 7.34 | 18:27:30 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.71 | 6.65 | 7.21 | 7.19 | 6.69 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,014 | 71,325 | US$ 6.97 | US$ 496,954 | - | 3.78 - 13.62 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:11:36 | 10 | US$ 7.30 | USD |
Pulse Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 395.39M | 54.99M | - | 0 | -42.21M | -0.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Pulse Biosciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/24/2024 | 15:05 | Business Wire | Pulse Biosciences Schedules First Quarter 2024 Financial.. |
| 3/28/2024 | 15:12 | Business Wire | Pulse Biosciences Reports Business Updates and Fourth.. |
| 3/28/2024 | 15:10 | Business Wire | Pulse Biosciences Announces Plans to Initiate a Rights.. |
| 3/14/2024 | 15:05 | Business Wire | Pulse Biosciences Schedules Fourth Quarter & Full Year 2023.. |
| 3/11/2024 | 08:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/08/2024 | 12:17 | Business Wire | Pulse Biosciences Announces FDA 510(k) Clearance for its.. |
| 2/14/2024 | 08:22 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/14/2024 | 07:00 | Business Wire | Pulse Biosciences Announces Positive 60-Day Follow-Up.. |
| 1/31/2024 | 07:00 | Business Wire | Pulse Biosciences Announces Preliminary Findings from its.. |
| 1/09/2024 | 08:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/02/2024 | 08:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/02/2024 | 07:00 | Business Wire | Pulse Biosciences Files 510(k) Submission with U.S. FDA for.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PLSE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.26 | 7.59 | 6.595 | 6.92 | 128,274 | 0.08 | 1.10% |
| 1 Month | 7.696 | 8.34 | 6.595 | 7.51 | 188,945 | -0.356 | -4.63% |
| 3 Months | 8.95 | 11.6398 | 6.595 | 8.70 | 165,686 | -1.61 | -17.99% |
| 6 Months | 4.01 | 13.62 | 3.78 | 9.02 | 231,853 | 3.33 | 83.04% |
| 1 Year | 5.87 | 13.62 | 3.78 | 7.85 | 198,581 | 1.47 | 25.04% |
| 3 Years | 21.02 | 29.16 | 1.18 | 7.25 | 153,651 | -13.68 | -65.08% |
| 5 Years | 16.47 | 45.82 | 1.18 | 9.76 | 128,119 | -9.13 | -55.43% |
Pulse Biosciences Description
| Pulse Biosciences Inc is a medical therapy company that pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage. Substantial revenue is generated from North America Majorly due to the sale of systems. |
